_id
695286c5c2e91020a7bc1270
Ticker
ZIVOW
Name
Zivo Bioscience Inc. Warrants
Exchange
NASDAQ
Address
2125 Butterfield Drive, Troy, MI, United States, 48084
Country
USA
Sector
Industry
Currency
USD
Website
https://www.zivobioscience.com
Description
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Last Close
0.55
Volume
3000
Current Price
0.044
Change
-92
Last Updated
2025-12-29T13:48:53.299Z
Ipo Date
2021-05-28T00:00:00.000Z
Market Cap
35328300
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
65625
Cost Of Revenue
44337
Gross Profit
21288
Operating Expenses
1039631
Operating Income
-1018343
Interest Expense
12959
Pretax Income
-1033056
Net Income
-1033056
Eps
-0.27063386192710204
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-1020097
Operating Margin
-1551.760761904762
Total Other Income Expense Net
-14713
Cash
57222
Short Term Investments
-
Receivables
0
Inventories
-
Total Current Assets
281399
Property Plant Equipment
270373
Total Assets
559452
Payables
992990
Short Term Debt
212172
Long Term Debt
11663
Total Liabilities
231787
Equity
-3286603
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-284028
Cash From Operations
-266556
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
313955
Net Change In Cash
47399
Cf_currency_symbol
USD
PE
-
PB
-0.05110308972516608
ROE
31.432333019838417
ROA
-184.6549838055812
FCF
-266556
Fcf Percent
-4.061805714285715
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
4
Growth Investing Score
4
Momentum Investing Score
4
Net Net Investing Score
0.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
65625
Quarters > 0 > income Statement > cost Of Revenue
44337
Quarters > 0 > income Statement > gross Profit
21288
Quarters > 0 > income Statement > operating Expenses
1039631
Quarters > 0 > income Statement > operating Income
-1018343
Quarters > 0 > income Statement > interest Expense
12959
Quarters > 0 > income Statement > pretax Income
-1033056
Quarters > 0 > income Statement > net Income
-1033056
Quarters > 0 > income Statement > eps
-0.27063386192710204
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3817172
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1020097
Quarters > 0 > income Statement > operating Margin
-1551.760761904762
Quarters > 0 > income Statement > total Other Income Expense Net
-14713
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
57222
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
281399
Quarters > 0 > balance Sheet > property Plant Equipment
270373
Quarters > 0 > balance Sheet > total Assets
559452
Quarters > 0 > balance Sheet > payables
992990
Quarters > 0 > balance Sheet > short Term Debt
212172
Quarters > 0 > balance Sheet > long Term Debt
11663
Quarters > 0 > balance Sheet > total Liabilities
231787
Quarters > 0 > balance Sheet > equity
-3286603
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1033056
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-284028
Quarters > 0 > cash Flow > cash From Operations
-266556
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
313955
Quarters > 0 > cash Flow > net Change In Cash
47399
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.27063386192710204
Quarters > 0 > ratios > PB
-0.05110308972516608
Quarters > 0 > ratios > ROE
31.432333019838417
Quarters > 0 > ratios > ROA
-184.6549838055812
Quarters > 0 > ratios > FCF
-266556
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-4.061805714285715
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
53400
Quarters > 1 > income Statement > cost Of Revenue
35478
Quarters > 1 > income Statement > gross Profit
17922
Quarters > 1 > income Statement > operating Expenses
1650794
Quarters > 1 > income Statement > operating Income
-1632872
Quarters > 1 > income Statement > interest Expense
7360
Quarters > 1 > income Statement > pretax Income
-1640232
Quarters > 1 > income Statement > net Income
-1640232
Quarters > 1 > income Statement > eps
-0.4304997421303836
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3810065
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1632872
Quarters > 1 > income Statement > operating Margin
-3057.8127340823967
Quarters > 1 > income Statement > total Other Income Expense Net
-7360
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
9823
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
34364
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
409894
Quarters > 1 > balance Sheet > property Plant Equipment
285753
Quarters > 1 > balance Sheet > total Assets
703327
Quarters > 1 > balance Sheet > payables
860939
Quarters > 1 > balance Sheet > short Term Debt
494648
Quarters > 1 > balance Sheet > long Term Debt
46962
Quarters > 1 > balance Sheet > total Liabilities
3244073
Quarters > 1 > balance Sheet > equity
-2540746
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1640230
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
626724
Quarters > 1 > cash Flow > cash From Operations
-476410
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-30956
Quarters > 1 > cash Flow > net Change In Cash
-507366
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.4304997421303836
Quarters > 1 > ratios > PB
-0.06598174709317657
Quarters > 1 > ratios > ROE
64.55710252028342
Quarters > 1 > ratios > ROA
-233.21044123146132
Quarters > 1 > ratios > FCF
-476410
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-8.921535580524344
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
0
Quarters > 2 > income Statement > operating Expenses
4208788
Quarters > 2 > income Statement > operating Income
-4208788
Quarters > 2 > income Statement > interest Expense
2400
Quarters > 2 > income Statement > pretax Income
-4211188
Quarters > 2 > income Statement > net Income
-4211188
Quarters > 2 > income Statement > eps
-1.1229598096466769
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3750079
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4208788
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-2400
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
517189
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
0
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1022923
Quarters > 2 > balance Sheet > property Plant Equipment
300731
Quarters > 2 > balance Sheet > total Assets
1331334
Quarters > 2 > balance Sheet > payables
655279
Quarters > 2 > balance Sheet > short Term Debt
699474
Quarters > 2 > balance Sheet > long Term Debt
81458
Quarters > 2 > balance Sheet > total Liabilities
2948613
Quarters > 2 > balance Sheet > equity
-1617279
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4211188
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-342696
Quarters > 2 > cash Flow > cash From Operations
-1430238
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
404985
Quarters > 2 > cash Flow > net Change In Cash
-1025253
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.1229598096466769
Quarters > 2 > ratios > PB
-0.10202536235244507
Quarters > 2 > ratios > ROE
260.3872306509885
Quarters > 2 > ratios > ROA
-316.31341196123583
Quarters > 2 > ratios > FCF
-1430238
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
90000
Quarters > 3 > income Statement > cost Of Revenue
63000
Quarters > 3 > income Statement > gross Profit
27000
Quarters > 3 > income Statement > operating Expenses
1623419
Quarters > 3 > income Statement > operating Income
-1596419
Quarters > 3 > income Statement > interest Expense
4966
Quarters > 3 > income Statement > pretax Income
-1601385
Quarters > 3 > income Statement > net Income
-1601385
Quarters > 3 > income Statement > eps
-0.46955323119218495
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3410444
Quarters > 3 > income Statement > income Tax Expense
1
Quarters > 3 > income Statement > EBITDA
-1596419
Quarters > 3 > income Statement > operating Margin
-1773.798888888889
Quarters > 3 > income Statement > total Other Income Expense Net
-4965
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1542442
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2211
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
1635442
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
1643122
Quarters > 3 > balance Sheet > payables
741852
Quarters > 3 > balance Sheet > short Term Debt
138164
Quarters > 3 > balance Sheet > long Term Debt
116197
Quarters > 3 > balance Sheet > total Liabilities
2158019
Quarters > 3 > balance Sheet > equity
-514897
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1601385
Quarters > 3 > cash Flow > depreciation
98280
Quarters > 3 > cash Flow > change In Working Capital
-71725
Quarters > 3 > cash Flow > cash From Operations
-905722
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2288761
Quarters > 3 > cash Flow > net Change In Cash
1383039
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.46955323119218495
Quarters > 3 > ratios > PB
-0.2914360270112275
Quarters > 3 > ratios > ROE
311.0107458384881
Quarters > 3 > ratios > ROA
-97.45989646538723
Quarters > 3 > ratios > FCF
-905722
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-10.063577777777779
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
157220
Annuals > 0 > income Statement > cost Of Revenue
108268
Annuals > 0 > income Statement > gross Profit
48952
Annuals > 0 > income Statement > operating Expenses
13410849
Annuals > 0 > income Statement > operating Income
-13361897
Annuals > 0 > income Statement > interest Expense
22939
Annuals > 0 > income Statement > pretax Income
-13384836
Annuals > 0 > income Statement > net Income
-13384836
Annuals > 0 > income Statement > eps
-3.924660835949806
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3410444
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-13361897
Annuals > 0 > income Statement > operating Margin
-8498.853199338506
Annuals > 0 > income Statement > total Other Income Expense Net
-22939
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1542442
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2211
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
1635442
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
1643122
Annuals > 0 > balance Sheet > payables
741852
Annuals > 0 > balance Sheet > short Term Debt
138164
Annuals > 0 > balance Sheet > long Term Debt
116197
Annuals > 0 > balance Sheet > total Liabilities
2158019
Annuals > 0 > balance Sheet > equity
-514897
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-13384836
Annuals > 0 > cash Flow > depreciation
98280
Annuals > 0 > cash Flow > change In Working Capital
-500467
Annuals > 0 > cash Flow > cash From Operations
-4313510
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
5581572
Annuals > 0 > cash Flow > net Change In Cash
1268062
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.924660835949806
Annuals > 0 > ratios > PB
-0.2914360270112275
Annuals > 0 > ratios > ROE
2599.5171849903963
Annuals > 0 > ratios > ROA
-814.5978204905052
Annuals > 0 > ratios > FCF
-4313510
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-27.436140440147565
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
27650
Annuals > 1 > income Statement > cost Of Revenue
16040
Annuals > 1 > income Statement > gross Profit
11610
Annuals > 1 > income Statement > operating Expenses
7274622
Annuals > 1 > income Statement > operating Income
-7263012
Annuals > 1 > income Statement > interest Expense
514172
Annuals > 1 > income Statement > pretax Income
-7777184
Annuals > 1 > income Statement > net Income
-7777184
Annuals > 1 > income Statement > eps
-4.601859516724467
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1690009
Annuals > 1 > income Statement > income Tax Expense
-167895
Annuals > 1 > income Statement > EBITDA
-7263012
Annuals > 1 > income Statement > operating Margin
-26267.674502712474
Annuals > 1 > income Statement > total Other Income Expense Net
-514172
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
274380
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3735
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
425377
Annuals > 1 > balance Sheet > property Plant Equipment
98280
Annuals > 1 > balance Sheet > total Assets
555715
Annuals > 1 > balance Sheet > payables
1165760
Annuals > 1 > balance Sheet > short Term Debt
346342
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2761558
Annuals > 1 > balance Sheet > equity
-2205843
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-7777184
Annuals > 1 > cash Flow > depreciation
439594
Annuals > 1 > cash Flow > change In Working Capital
1280668
Annuals > 1 > cash Flow > cash From Operations
-5799893
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
4275010
Annuals > 1 > cash Flow > net Change In Cash
-1524883
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-4.601859516724467
Annuals > 1 > ratios > PB
-0.03371064758461957
Annuals > 1 > ratios > ROE
352.5719645505142
Annuals > 1 > ratios > ROA
-1399.4914659492724
Annuals > 1 > ratios > FCF
-5799893
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-209.76104882459313
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
8731974
Annuals > 2 > income Statement > operating Income
-8731974
Annuals > 2 > income Statement > interest Expense
13319
Annuals > 2 > income Statement > pretax Income
-8745293
Annuals > 2 > income Statement > net Income
-8745293
Annuals > 2 > income Statement > eps
-5.570449009646204
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1569944
Annuals > 2 > income Statement > income Tax Expense
-4
Annuals > 2 > income Statement > EBITDA
-8731974
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-13319
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1799263
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
0
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1901679
Annuals > 2 > balance Sheet > property Plant Equipment
189282
Annuals > 2 > balance Sheet > total Assets
2123019
Annuals > 2 > balance Sheet > payables
490670
Annuals > 2 > balance Sheet > short Term Debt
339259
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2133641
Annuals > 2 > balance Sheet > equity
-10622
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-8745293
Annuals > 2 > cash Flow > depreciation
-774025
Annuals > 2 > cash Flow > change In Working Capital
-355393
Annuals > 2 > cash Flow > cash From Operations
-7102612
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-628600
Annuals > 2 > cash Flow > net Change In Cash
-7102612
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-5.570449009646204
Annuals > 2 > ratios > PB
-6.5032513650913195
Annuals > 2 > ratios > ROE
82331.88665034834
Annuals > 2 > ratios > ROA
-411.92721308664693
Annuals > 2 > ratios > FCF
-7102612
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
9052605
Annuals > 3 > income Statement > operating Income
-9052605
Annuals > 3 > income Statement > interest Expense
233281
Annuals > 3 > income Statement > pretax Income
-9163366
Annuals > 3 > income Statement > net Income
-9396647
Annuals > 3 > income Statement > eps
-7.390136310156727
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1271512
Annuals > 3 > income Statement > income Tax Expense
233281
Annuals > 3 > income Statement > EBITDA
-9608350
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-110761
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
8901875
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
8959953
Annuals > 3 > balance Sheet > property Plant Equipment
27225
Annuals > 3 > balance Sheet > total Assets
8990178
Annuals > 3 > balance Sheet > payables
654333
Annuals > 3 > balance Sheet > short Term Debt
255178
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2947969
Annuals > 3 > balance Sheet > equity
6042209
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-9163366
Annuals > 3 > cash Flow > depreciation
-555745000
Annuals > 3 > cash Flow > change In Working Capital
-394127
Annuals > 3 > cash Flow > cash From Operations
-6803333
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
15567346
Annuals > 3 > cash Flow > net Change In Cash
8764013
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-7.390136310156727
Annuals > 3 > ratios > PB
0.009259283814909414
Annuals > 3 > ratios > ROE
-155.51674892411037
Annuals > 3 > ratios > ROA
-104.52125642006197
Annuals > 3 > ratios > FCF
-6803333
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.27063386192710204
Valuation > metrics > PB
-0.05110308972516608
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
31.432333019838417
Profitability > metrics > ROA
-367.11431099613003
Profitability > metrics > Net Margin
-15.741805714285714
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-78.58191218458214
Risk > final Score
-284
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.23349475008339127
Liquidity > metrics > Quick Ratio
0.23349475008339127
Liquidity > final Score
22
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
55
Prev Profitabilities > 2
40
Prev Risks > 0
-857
Prev Risks > 1
-6985
Prev Risks > 2
-1256
Prev Liquidities > 0
25
Prev Liquidities > 1
48
Prev Liquidities > 2
96
Updated At
2026-01-20T23:12:49.612Z
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Zivo Bioscience Inc. Warrants
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.